These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 23495692)

  • 1. Pharmacological approaches to the treatment of oxidative stress-induced cardiovascular dysfunctions.
    Zamora PL; Villamena FA
    Future Med Chem; 2013 Mar; 5(4):465-78. PubMed ID: 23495692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is mycophenolate more than just an immunosuppressant?--An overview.
    Iyer A; Brown L
    Indian J Biochem Biophys; 2009 Feb; 46(1):25-30. PubMed ID: 19374250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New opportunities for targeting redox dysregulation in cardiovascular disease.
    Bubb KJ; Drummond GR; Figtree GA
    Cardiovasc Res; 2020 Mar; 116(3):532-544. PubMed ID: 31297507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.
    Montezano AC; Touyz RM
    Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelins and NADPH oxidases in the cardiovascular system.
    Dammanahalli KJ; Sun Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):2-6. PubMed ID: 18047620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive species and diabetes: counteracting oxidative stress to improve health.
    Pérez-Matute P; Zulet MA; Martínez JA
    Curr Opin Pharmacol; 2009 Dec; 9(6):771-9. PubMed ID: 19766058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapeutic approaches in limiting oxidative stress and inflammation.
    Spychalowicz A; Wilk G; Śliwa T; Ludew D; Guzik TJ
    Curr Pharm Biotechnol; 2012 Oct; 13(13):2456-66. PubMed ID: 22280420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic antioxidant potential of rosuvastatin in preventing cardiovascular disorders.
    Mahalwar R; Khanna D
    Eur J Pharmacol; 2013 Jul; 711(1-3):57-62. PubMed ID: 23648561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidants in cardiovascular health and disease: key lessons from epidemiologic studies.
    Willcox BJ; Curb JD; Rodriguez BL
    Am J Cardiol; 2008 May; 101(10A):75D-86D. PubMed ID: 18474278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular NADPH oxidases as drug targets for novel antioxidant strategies.
    Guzik TJ; Harrison DG
    Drug Discov Today; 2006 Jun; 11(11-12):524-33. PubMed ID: 16713904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress in patients with cardiovascular disease and chronic renal failure.
    Popolo A; Autore G; Pinto A; Marzocco S
    Free Radic Res; 2013 May; 47(5):346-56. PubMed ID: 23438723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress in vascular disease and its pharmacological prevention.
    Li H; Horke S; Förstermann U
    Trends Pharmacol Sci; 2013 Jun; 34(6):313-9. PubMed ID: 23608227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease.
    Pashkow FJ; Watumull DG; Campbell CL
    Am J Cardiol; 2008 May; 101(10A):58D-68D. PubMed ID: 18474276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is oxidative stress a therapeutic target in cardiovascular disease?
    Münzel T; Gori T; Bruno RM; Taddei S
    Eur Heart J; 2010 Nov; 31(22):2741-8. PubMed ID: 20974801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and cardiovascular health: therapeutic potential of polyphenols.
    Khurana S; Piche M; Hollingsworth A; Venkataraman K; Tai TC
    Can J Physiol Pharmacol; 2013 Mar; 91(3):198-212. PubMed ID: 23537433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in oxidative stress and the impact on blood pressure control and cardiovascular disease.
    Sartori-Valinotti JC; Iliescu R; Fortepiani LA; Yanes LL; Reckelhoff JF
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):938-45. PubMed ID: 17645644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria-Targeted Antioxidants for the Treatment of Cardiovascular Disorders.
    Kim HK; Han J
    Adv Exp Med Biol; 2017; 982():621-646. PubMed ID: 28551810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
    Paravicini TM; Touyz RM
    Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective actions of melatonin and growth hormone on the aged cardiovascular system.
    Paredes SD; Forman KA; García C; Vara E; Escames G; Tresguerres JA
    Horm Mol Biol Clin Investig; 2014 May; 18(2):79-88. PubMed ID: 25390004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria induce oxidative stress, generation of reactive oxygen species and redox state unbalance of the eye lens leading to human cataract formation: disruption of redox lens organization by phospholipid hydroperoxides as a common basis for cataract disease.
    Babizhayev MA
    Cell Biochem Funct; 2011 Apr; 29(3):183-206. PubMed ID: 21381059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.